Zhangzhou Narcissus Pharmaceutical Co.,Ltd. announced that it will issue common shares in a round of funding on October 25, 2022. The transaction will include participation from returning investor Fujian Qingshan Paper Industry Co.,Ltd. The transaction has been approved in the 1st Extraordinary Shareholders Meeting of 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.15 CNY | +2.38% | +3.86% | -10.04% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.04% | 657M | |
+27.53% | 5.99B | |
+27.37% | 2.59B | |
-2.91% | 1.61B | |
+8.22% | 1.51B | |
-17.15% | 1.19B | |
+19.17% | 1.03B | |
-7.25% | 984M | |
-17.54% | 876M | |
-12.82% | 804M |
- Stock Market
- Equities
- 600103 Stock
- News Fujian Qingshan Paper Industry Co., Ltd.
- Zhangzhou Narcissus Pharmaceutical Co.,Ltd. announced that it expects to receive funding from Fujian Qingshan Paper Industry Co.,Ltd.